BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 7, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2020
View Archived Issues
SERPINB3 targeting proven useful for treating NASH
Read More
Benzodiazepine and barbiturate binding to GABA-A
Read More
Giving misfolded proteins a second chance
Read More
Agrin-culture grows cartilage
Read More
SCAD versus plaques in heart attacks
Read More
Zion initiates phase I study in U.S. with ZN-A-1041
Read More
FDA approves Detectnet
Read More
New personalized cystic fibrosis treatment treats Class V mutations
Read More
First patient dosed in triple combination study of COM-701 plus Opdivo and BMS-986207
Read More
Arcutis accelerates ARQ-151 into phase III trials for the treatment of atopic dermatitis
Read More
First phase I data presented for the neutrophil elastase inhibitor BI-1323495
Read More
Opaganib demonstrates complete inhibition of SARS-CoV-2 in vitro
Read More
First subject dosed in phase I study of ALLN-346
Read More
Positive and statistically significant topline data from the pivotal LOGICS study of Recorlev
Read More
Enrollment begins in phase I study of AG-946
Read More
Phase III trial of odevixibat in progressive familial intrahepatic cholestasis meets endpoints
Read More
Janssen describes new anti-hepatitis B virus compounds
Read More
Asceneuron discovers N-acetyl-beta-D-glucosaminidase inhibitors
Read More
Sichuan Kelun-Biotech Biopharmaceutical patents NLRP3 agonists
Read More
Results from a phase IIa POC trial of the oral adenosine A1 receptor antagonist PBF-680
Read More
New thyroid hormone receptor alpha/beta agonists discovered at Nanjing Ruijie Pharma
Read More
Cervello Therapeutics describes new Rho-associated protein kinase inhibitors
Read More
Immunocore's bispecific ImmTAV molecules eliminate HBV-infected cells
Read More
Argenx begins first-in-human study of ARGX-117
Read More
LNC obtains IND clearance for phase I trial of Xla-1 for obesity
Read More
FDA clears IND for phase I study of anti-CD19 CAR-T cell therapy CB-010 for B-NHL
Read More
FDA accepts IND for phase I study of ATA-2271 for advanced mesothelioma
Read More